Forte Biosciences, Inc. (NasdaqGM: FBRX)
Health Care · Biotechnology · US
$76.99
+0.03% today · +311.5% 1Y
Public summary
A free snapshot of Forte Biosciences, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Forte Biosciences, Inc. (NasdaqGM: FBRX) operates in the Biotechnology industry within the Health Care sector.
Over the last twelve months the share price has gained 311.5%, trading between 15.51 and 77.20.
Tweenvest scores Forte Biosciences, Inc. across four factors: quality 35/100, value 100/100. Its strongest factor is value.
FBRX price history
Key figures
- Market cap
- —
- Revenue (TTM)
- —
- P/E
- -22.05
- EPS
- -4.56
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $77.20
- 52-week low
- $15.51
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 23
- Next earnings
- —
About Forte Biosciences, Inc.
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.
- ISIN
- US34962G2084
- Listed since
- Apr 13, 2017
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Rebus Holdings, Inc.OTCPK: RBSH | $32.00 | $0.00 | -99.00% |
| HAVN Life Sciences Inc.OTCPK: HAVL.F | $29.00 | $0.00 | 0.00% |
| TetraLogic Pharmaceuticals CorporationOTCPK: TLOG | $24.00 | $0.00 | -99.00% |
| IMV Inc.OTCPK: IMVI.F | $15.00 | $0.00 | -99.00% |
| PhaseRx, Inc.OTCPK: PZRX.Q | $12.00 | $0.00 | 0.00% |
| ContraFect CorporationOTCPK: CFRX.Q | $11.00 | $0.00 | 0.00% |
| Notable Labs, Ltd.OTCPK: NTBL.Q | $10.00 | $0.00 | 0.00% |
| OncoSec Medical IncorporatedOTCPK: ONCS.Q | $6.00 | $0.00 | 0.00% |